Condition
RTT
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
2 of 0 completed with results
Key Signals
2 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Recruiting2
Terminated2
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05932589Recruiting
Neurophysiologic Biomarkers in Rett Syndrome
NCT06346106Recruiting
The Diagnostic Experience of Male Rett Syndrome
NCT03848832Phase 3Terminated
Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT04252586Phase 3Terminated
A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT03175328Not ApplicableUnknown
CRRT Timing in Sepsis-associated AKI in ICU
Showing all 5 trials